These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12484239)

  • 1. Expression of cytochrome P450 enzymes in human colon.
    Bernauer U; Ellrich R; Heinrich-Hirsch B; Teubner W; Vieth B; Gundert-Remy U
    IARC Sci Publ; 2002; 156():487-9. PubMed ID: 12484239
    [No Abstract]   [Full Text] [Related]  

  • 2. Xenobiotic metabolising enzyme expression in colonic neoplasia.
    McKay JA; Murray GI; Weaver RJ; Ewen SW; Melvin WT; Burke MD
    Gut; 1993 Sep; 34(9):1234-9. PubMed ID: 8406161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
    Kumarakulasingham M; Rooney PH; Dundas SR; Telfer C; Melvin WT; Curran S; Murray GI
    Clin Cancer Res; 2005 May; 11(10):3758-65. PubMed ID: 15897573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some aspects of interindividual variations in the metabolism of xenobiotics.
    Tamási V; Vereczkey L; Falus A; Monostory K
    Inflamm Res; 2003 Aug; 52(8):322-33. PubMed ID: 14504670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically engineered in vitro systems for biotransformation studies.
    Doehmer J; Schmalix WA; Greim H
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):513-8. PubMed ID: 7885078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytochromes P450: xenobiotic metabolism, regulation and clinical importance].
    Guéguen Y; Mouzat K; Ferrari L; Tissandie E; Lobaccaro JM; Batt AM; Paquet F; Voisin P; Aigueperse J; Gourmelon P; Souidi M
    Ann Biol Clin (Paris); 2006; 64(6):535-48. PubMed ID: 17162257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.
    Downie D; McFadyen MC; Rooney PH; Cruickshank ME; Parkin DE; Miller ID; Telfer C; Melvin WT; Murray GI
    Clin Cancer Res; 2005 Oct; 11(20):7369-75. PubMed ID: 16243809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk.
    Payne CM; Holubec H; Bernstein C; Bernstein H; Dvorak K; Green SB; Wilson M; Dall'Agnol M; Dvorakova B; Warneke J; Garewal H
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2066-75. PubMed ID: 16172211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cytochrome P450 gene expression in the olfactory mucosa.
    Ling G; Gu J; Genter MB; Zhuo X; Ding X
    Chem Biol Interact; 2004 Apr; 147(3):247-58. PubMed ID: 15135081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Xenobiotics and transcriptional regulation].
    Mimura J; Fujii-Kuriyama Y
    Tanpakushitsu Kakusan Koso; 2003 Dec; 48(16):2261-6. PubMed ID: 14661584
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene regulation. One man's food.
    Lazar MA
    Nature; 2000 Oct; 407(6806):852-3. PubMed ID: 11057652
    [No Abstract]   [Full Text] [Related]  

  • 12. Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics.
    Pool-Zobel BL; Selvaraju V; Sauer J; Kautenburger T; Kiefer J; Richter KK; Soom M; Wölfl S
    Carcinogenesis; 2005 Jun; 26(6):1064-76. PubMed ID: 15746163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines.
    Brandon EF; Bosch TM; Deenen MJ; Levink R; van der Wal E; van Meerveld JB; Bijl M; Beijnen JH; Schellens JH; Meijerman I
    Toxicol Appl Pharmacol; 2006 Feb; 211(1):1-10. PubMed ID: 15975613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochromes P450, drugs, and diseases.
    Guengerich FP
    Mol Interv; 2003 Jun; 3(4):194-204. PubMed ID: 14993447
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparisons of (+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol activation by human cytochrome P450 and aldo-keto reductase enzymes: effect of redox state and expression levels.
    Quinn AM; Penning TM
    Chem Res Toxicol; 2008 May; 21(5):1086-94. PubMed ID: 18402469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA expression of cytochrome P450 in breast cancer patients.
    Vaclavikova R; Hubackova M; Stribrna-Sarmanova J; Kodet R; Mrhalova M; Novotny J; Gut I; Soucek P
    Anticancer Res; 2007; 27(6C):4443-50. PubMed ID: 18214058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation.
    Cribb AE; Knight MJ; Dryer D; Guernsey J; Hender K; Tesch M; Saleh TM
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):551-8. PubMed ID: 16537715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver.
    Haas S; Merkelbach-Bruse S; Justenhoven C; Brauch H; Fischer HP
    Pathol Res Pract; 2009; 205(10):716-25. PubMed ID: 19596526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the world of cytochrome P450 enzymes.
    Frye RF
    Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions.
    Lee MD; Ayanoglu E; Gong L
    Xenobiotica; 2006; 36(10-11):1013-80. PubMed ID: 17118918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.